Sort
17,828 grants matching “crispr”
Systematic mapping and prediction of gene-enhancer connections
$284,628Jesse M Engreitz · Stanford University · R00 · FY2021 · HG
PDX tumor-TME acquired resistance
$284,529Jack Roth · University Of California, San Francisco · U54 · FY2025 · CA
Exploiting myeloma proteome remodeling to extend proteasome inhibitor efficacy
$284,107Arun P. Wiita · University Of California, San Francisco · R01 · FY2021 · CA
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer
$284,061William G Kaelin · Beth Israel Deaconess Medical Center · P50 · FY2021 · CA
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$284,032Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Bacteriophage-host dynamics as a factor in the etiology of bacterial vaginosis
$284,000K Eric Eric Wommack · University Of Delaware · R21 · FY2014 · AI
Targeting Mechanisms of Endocrine Resistance in Breast Cancer
$283,987Myles A Brown · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Investigation of energetics of sharp DNA bending
$283,739Harold D Kim · Georgia Institute Of Technology · R01 · FY2020 · GM
Project 4. Targeting genomic instability and evolution in myeloma
$283,713Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2017 · CA
The mechanism of Cas9/CRISPR-initiated genome modification in human somatic cells
$283,657Eric A Hendrickson · University Of Minnesota · R01 · FY2017 · GM
The mechanism of Cas9/CRISPR-initiated genome modification in human somatic cells
$283,657Eric A Hendrickson · University Of Minnesota · R01 · FY2015 · GM
The mechanism of Cas9/CRISPR-initiated genome modification in human somatic cells
$283,657Eric A Hendrickson · University Of Minnesota · R01 · FY2018 · GM
The mechanism of Cas9/CRISPR-initiated genome modification in human somatic cells
$283,657Eric A Hendrickson · University Of Minnesota · R01 · FY2016 · GM
Oncogenic mechanisms and molecular targets in myeloma
$283,652Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
PDX tumor-TME acquired resistance
$283,621Jack Roth · University Of California, San Francisco · U54 · FY2023 · CA
Mechanisms of CRISPR Interference
$283,569Erik J Sontheimer · Northwestern University · R01 · FY2012 · GM
Core C: Genome Engineering Core
$283,535Bruce R Conklin · J. David Gladstone Institutes · P01 · FY2020 · HL
Core C: Genome Engineering Core
$283,535Bruce R Conklin · J. David Gladstone Institutes · P01 · FY2021 · HL
Core C: Genome Engineering Core
$283,535Bruce R Conklin · J. David Gladstone Institutes · P01 · FY2022 · HL
Core C: Genome Engineering Core
$283,535Bruce R Conklin · J. David Gladstone Institutes · P01 · FY2023 · HL
Enhancing endoplasmic reticulum stress in ovarian cancer
$283,533Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Exploiting myeloma proteome remodeling to extend proteasome inhibitor efficacy
$283,519Arun P. Wiita · University Of California, San Francisco · R01 · FY2019 · CA
The molecular genetic analysis of human obesity
$283,500Rudolph L Leibel · Columbia University Health Sciences · R01 · FY2018 · DK
Targeted Delivery of Cas9 to Lung Epithelial Cells using Enveloped Delivery Vehicles
$283,500Jennifer A Doudna · J. David Gladstone Institutes · R21 · FY2025 · HL
Project 3. Oncogenomics to identify and validate novel targeted therapies in myeloma
$283,488Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2017 · CA